This Experimental “Super Vaccine” Stopped Cancer Cold in the Lab

This experimental “super vaccine” stopped cancer cold in the lab

UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, pancreatic, and triple-negative breast cancers in mice—with up to 88% remaining tumor-free. The vaccine triggers a multi-pathway immune response, producing powerful T-cell activation and long-term immune memory that stops both tumor growth and metastasis. By combining cancer-specific antigens with a lipid nanoparticle “super adjuv…

Nanoparticle vaccine preventa cancer spread in mice

Illustrated cross section of a lipid nanoparticle. The nanoparticles in this study contained a payload of adjuvants and cancer antigens. Credit: Love Employee/Getty Images A nanoparticle system for delivering vaccines has been shown to prevent the development and reduce the spread of melanoma, pancreatic and triple-negative breast cancer in mice. The team from the University of Massachusetts Amherst in the US believes their vaccine may also work…

Scientists have created a cancer vaccine that stops its aggressive form in 88% of cases in mice - Global Happenings

Cancer vaccine She showed the results During studies on mice. The drug prevented up to 88% of aggressive cancers.including melanoma and pancreatic cancer. The study results were published in the journal Cell Reports Medicine. The study was conducted by scientists at the University of Massachusetts. A team of scientists from the University of Massachusetts (UMASS) in Amherst developed an experimental cancer vaccinewhich has demonstrated high effi…